Cerdanyola del Valles, Spain

Veronica Jiménez Cenzano

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Veronica Jiménez Cenzano

Introduction

Veronica Jiménez Cenzano is a notable inventor based in Cerdanyola del Valles, Spain. She has made significant contributions to the field of biotechnology, particularly in the development of gene constructs. Her work focuses on innovative solutions that have the potential to impact medical science.

Latest Patents

One of her key patents is a single-vector gene construct comprising insulin and glucokinase genes. This invention relates to a viral expression construct and related viral vector and composition. The construct and vector include elements such as a nucleotide sequence encoding insulin operably linked to a first promoter and a nucleotide sequence encoding glucokinase operably linked to a second promoter. Additionally, the viral expression construct and related viral vector may comprise elements where the first and second promoters are positioned in reverse orientation within the expression construct. The first promoter is identified as a CMV promoter, preferably a mini CMV promoter. This patent showcases her innovative approach to gene therapy.

Career Highlights

Veronica is affiliated with the Universitat Autònoma de Barcelona, where she continues her research and development in biotechnology. Her academic background and professional experience have positioned her as a leader in her field.

Collaborations

She has collaborated with esteemed colleagues such as Fatima Bosch Tubert and Miguel Garcia Martinez. These partnerships have further enhanced her research capabilities and contributed to her success in the field.

Conclusion

Veronica Jiménez Cenzano's work exemplifies the intersection of innovation and biotechnology. Her contributions, particularly in gene constructs, hold promise for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…